Archives
Adjuvant Pembrolizumab Cuts Recurrence in Stage II Melanoma
Compared with placebo, pembrolizumab prolonged regression-free survival in resected high-risk stage IIB and IIC melanoma
Workers at the World Trade Center Site Face Higher Risk for COPD
Rescue and recovery workers who arrived at the site early and those with a previous asthma diagnosis face the greatest risk for developing COPD
Periodontitis May Raise Risk for New Cardiovascular Events
Presence of periodontitis at baseline linked to increased odds for new cardiovascular events
Predictors of Upper GI Bleeding Identified After Acute MI
UGIB after MI linked to increased risk for all-cause mortality and stroke, but not recurrent myocardial infarction; predictors of UGIB include age and smoking status
Fixed-Dose Combination Therapies Reduce Cardiovascular Risk
Fixed-dose combo with BP-lowering meds, statin, and aspirin yields largest reduction in cardiovascular risk
AAOS: Knee Replacement Readmissions Higher Among Marijuana Users
Readmission rates higher for preoperative marijuana users compared with nonusers at 90 days and at one year following total knee arthroplasty
Ultra-Low-Dose Combo Cuts Systolic BP in Hypertension
Reduction in systolic blood pressure greater at week 12 with fixed-dose quadruple quarter-dose combo versus standard-dose monotherapy
Global Dementia Cases Projected to Top 152 Million in 2050
Increases in cases mainly due to population growth and aging, with relative importance of these factors varying by region
Cognitive Impairment Reported After COVID-19 Infection
Cognitive impairment identified in cohort of older Amerindians and in 32 patients after mild-to-moderate COVID-19
Return to Play Seems Safe for Most Athletes With Long QT Syndrome
No genetic heart disease-sports-associated mortality seen in 2,056 combined years of follow-up
